ProPhase Labs's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
ProPhase Labs (NASDAQ:PRPH) is expected to report a Q4 earnings per share (EPS) of $-0.26 on March 15, 2024. Analysts and investors will be looking for the company to beat this estimate and provide positive guidance for the next quarter. The company's past earnings performance shows a pattern of not meeting EPS estimates, leading to significant drops in share price. Shares are currently trading at $5.05, down 35.96% over the last 52 weeks, indicating a bearish outlook from long-term shareholders.
March 14, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ProPhase Labs is anticipated to report a Q4 EPS of $-0.26, with investors hoping for a beat and positive future guidance. Historical performance shows a trend of not meeting EPS estimates, negatively impacting the stock price.
Given ProPhase Labs's history of not meeting EPS estimates and the subsequent negative impact on its stock price, it's likely that if the company fails to meet or exceed the expected EPS of $-0.26, the stock price could experience another drop. The anticipation of positive guidance could mitigate this impact, but the historical trend suggests a cautious outlook.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100